Filter & sort
The latest funding rounds from the UK tech ecosystem. Updated 5 August 2026.
Announcements
5,266
Total raised
£159B
disclosed amounts
This month
£244M
raised so far
The female-founded corporate gifting platform has closed a seed round backed by Clarendon Fund Managers and Techstart Ventures.
"Needi's seamless, tech-driven solution to sourcing high quality, unique gifts has the potential to revolutionise corporate gifting strategies."
The seed round was led by Heal Capital to support platform development and expand community-based care pathways.
"For a long time, healthcare was rooted in the community. This brought so many benefits to both patients and practitioners, but in recent decades it’s become completely cost-ineffective to deliver it. Meanwhile, secondary care is becoming increasingly bottlenecked, with waiting lists at an all-time high and discharge delays keeping patients in hospital longer than they need. Our mission with Heim Health is to build the digital infrastructure needed to change this; revitalising community-based care and moving more healthcare from the hospital into the home through scalable modes of delivery."
The London-based SaaS and fintech platform raised the funds from General Catalyst, Morpheus Ventures and Repeat to further develop its technology stack.
"Goodstack enables its customers to serve all stakeholders—employees, customers, and communities—by supporting nonprofits and charitable giving. The validation and trust that partners like LinkedIn and Canva have in Goodstack is a powerful testament to the company’s value, and combined with strong leadership, positions Goodstack well for continued success."
The Series A financing was led by Par Equity to support international expansion and product development.
"Securing this investment allows us to scale our impact across healthcare and life sciences, with a focus on easing the burden of paediatric clinical trials. While legislation like RACE, SPCs, and the ODA has increased study numbers, specialist paediatric knowledge is still lacking in the industry. This has led to lower recruitment, adherence and trial completion rates compared to adult research. Little Journey is uniquely positioned to fill this expertise gap and tackle these challenges to advance global paediatric medicine. With the backing of Par Equity, Mercia Ventures, Octopus Ventures, and our wider investor network, we’re redefining how paediatric clinical trials are run and putting families at the heart of them."
Northern Gritstone led the seed extension round, which included participation from ACF Investors, Empirical Ventures, Deeptech Labs, and Hamamatsu Ventures.
"The progress made by the Silveray team since our initial investment in 2023 has been phenomenal. Dan Cathie and his team have the enviable combination of innovation and entrepreneurialism having developed a novel digital x-ray solution with numerous applications which are already disrupting the analogue x-ray market. We are delighted to continue our support of Silveray as it builds its commercial traction, helping the team on its path to success."
